Cost analysis for CPT 0315U — Mrna gene expression profiling by real-time polymerase chain reaction (rt-pcr) of 40 genes (34 content and 6 housekeeping) associated with squamous cell carcinoma of skin in formalin-fixed paraffin-embedded (ffpe) tissue specimen, algorithm reported as ben
Average Medicare Payment
$6379.30
2023 data
Total Payments (2023)
$32.0M
Services (2023)
5.0K
Price Change (2022–2023)
+67.6%
| Year | Avg Payment | Total Payments | Services | YoY Change |
|---|---|---|---|---|
| 2022 | $3806.27 | $7.6M | 2.0K | — |
| 2023 | $6379.30 | $32.0M | 5.0K | +67.6% |
The most expensive state pays 1.0x more than the cheapest for this procedure. PA averages $6379.30 vs PA at $6379.30.
| State | Avg Payment | Total Payments | Services | Providers |
|---|---|---|---|---|
| PA | $6379.30 | $32.0M | 5.0K | 1 |
| Provider | Specialty | State | Payments | Services | Avg/Service |
|---|---|---|---|---|---|
| Cernostics, Inc. | Clinical Laboratory | PA | $32.0M | 5.0K | $6379.30 |
Based on the data, CPT 0315U shows a 1.0x variation in pricing across states — relatively consistent by Medicare standards.
Costs have increased 67.6% since 2022. Medicare's fee schedule attempts to standardize pricing, though some variation is expected due to geographic cost-of-living adjustments and practice expense differences.
This analysis is based on publicly available CMS data and does not account for patient complexity, comorbidities, or facility-specific factors that may justify pricing differences.
Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.